Vaccination demand increased, vaccine bioETFs and biomedical ETFs bucked the trend

On November 30, the vaccine sector bucked the trend. Junshi Biotech and Watson Biotech rose more than 5%, while Bosch Fund Vaccine Biotech ETF, Cathay Fund Vaccine ETF, Cathay Pacific Fund Vaccine ETF, China Merchants Fund Vaccine Leading ETF, Tianhong Fund Biomedical ETF, Wells Fargo Fund Vaccine Index ETF, Penghua Fund Biovaccine ETF, Cathay Pacific Fund Biomedical ETF, and Yifangda Fund Biotechnology ETF rose. The Vaccine Biology ETF tracks the China Securities Vaccine and Biotechnology Index, which selects no more than 50 businesses in the Shanghai and Shenzhen markets involving vaccine research and development, vaccine production, vaccine consumables, and the epidemic

Gelonghui FinanceNov 30, 2023 11:47

The National Health and Health Commission issued guidelines to strengthen the investigation of immigrants, and pharmaceutical ETFs continue to rise

The Zhitong Finance App learned that on July 4, pharmaceutical ETFs picked up due to news that the National Health and Health Commission issued guidelines to strengthen the investigation of immigrants. As of press release, the Hang Seng Healthcare ETF (513060.SH) had risen more than 3%, while pharmaceutical ETFs (512010.SH) and biopharmaceutical ETFs (159839.SZ) had risen more than 2.5%. On July 1, the National Health and Health Commission issued the “Technical Guidelines for the Prevention and Control of Monkeypox (2022 Edition)”. The guidelines mentioned that during the current quarantine period for immigrants, while investigating COVID-19 infections, all regions should take the initiative to investigate entrants for the monkeypox virus, especially

Zhitong FinanceJul 4, 2022 10:20

A big explosion in pharmaceutical stocks! Is the best place to buy now? Public funds are urgently disbanded

Cao Wenjing, a reporter from China Fund News, has been silent about pharmaceutical stocks for a long time and has once again become the brightest child in the entire market. As of today's closing, the biomedical sector had risen 4.25%, ranking 1st in Shenwan's Tier 1 industry. Among them, the CRO index of the segmented industry surged 8.60%, the medical services index surged 6.40%, and individual stocks showed a surge of ups and downs. In addition, more than 30 pharmaceutical ETFs surged more than 4%. Among them, nearly 10 pharmaceutical ETFs rose more than 5%. The Zhongguancun ETF, which heavily holdings pharmaceutical stocks such as Aimeike, Wantai Biotech, Lepu Healthcare, and Tong Ren Tang, rarely rose or stopped. A number of fund managers said that there has been a sharp rise in the pharmaceutical sector today.

中國基金報Sep 6, 2021 19:57

爆款新基金积极建仓 主攻顺周期方向

偏股基金热销已持续数月，这段时间成立的新基金建仓较为积极，一些爆款已有不错的收益。多位近期发行新产品的基金经理表示，一季度市场行情普遍不错，为把握机会新基金建仓速度也会适度加快，根据目前的市场环境，投资方向偏向顺周期领域。春节后市场震荡，优质“抱团股”大跌，基金经理也在密切关注市场震荡给优质个股带来的布局机遇。爆款基金是市场各方关注的焦点。今年以来成立的新基金积极建仓抓住了新年的投资机遇。创出单只

證券時報Feb 23, 2021 09:52